The Antibody Lab GmbH is a private biotechnology company with proprietary antibody engineering and protein expression technologies. The company follows a B2B business model, developing immunoassays and preclinical biologics for its partners and customers. The Antibody Lab’s research projects focus on antibodies and vaccines for human and veterinary medicine. The Antibody Lab is financed by its founders and by a revenue stream from existing partnerships with various life science companies.
Some of its R&D projects are supported by grants from Austrian (FFG, Wirtschaftsagentur Wien, aws) and European public agencies.
From the publishers of Nature, the BioPharma Dealmakers website brings together life sciences companies and individuals looking to identify and attract partners and dealmaking opportunities. It provides insights into dealmaking trends from BioPharma Dealmakers Editors, profiles from companies looking to partner, tools for networking and sharing knowledge, and the opportunity for sponsoring companies to showcase their expertise. BioPharma Dealmakers is THE destination for partnering professionals looking to make connections and get the latest on their industry.